Engineers at MIT and the Singapore-MIT Alliance for Research and Technology have made a dry, stretchy bottlebrush elastomer that transmits ultrasound without the wet gel used in a clinic, and have tested it on a phantom and in short demonstrations on volunteers. The work appears in a Science paper published on 19 November 2026, “Interpenetrating bottlebrush elastomer for low-loss soft ultrasonic interfaces,” and in an MIT News account of the same day. It is research-stage work. It has not been clinically validated and has not been cleared by any regulator.
The problem the team is trying to fix is practical. Wearable ultrasound patches need a layer that couples the probe to the skin. In previous designs from MIT’s Zhao Lab, that layer has been a hydrogel, which MIT News says can dry out “within a day or two” and lose its ability to carry sound. “In a doctor’s office, a technician can simply apply more gel if needed. But for a wearable device, gel-based designs can limit their long-term usability,” says Xuanhe Zhao, the Uncas and Helen Whitaker Professor of Mechanical Engineering at MIT.
The new material is liquid-free from the start. Shu Wang, a postdoctoral researcher in MIT’s Department of Mechanical Engineering and the study’s lead author, describes it as skin-like: “It’s very much like skin. It’s very soft but will hold together if pinched or pulled.” The engineers built it from bottlebrush polymer networks, then reinforced a first, crumbly network by chemically fusing it with a second, loosely connected bottlebrush network. Co-authors include researchers at the University of Wisconsin–Madison, the National University of Singapore and Nanyang Technological University. Zhao, Xiaodong Chen and Chwee Teck Lim are named as co-lead principal investigators of SMART WITEC, the Wearable Imaging for Transforming Elderly Care group.
On a phantom that mimics skin and internal structures, MIT News says the material “kept imaging clearly for around nine days.” Wang adds that, in principle, the sound properties could remain stable for longer, depending on how stable the material is. That is a laboratory statement about a phantom, not a nine-day result in patients.
The volunteer tests are shorter, and small. A patch on a volunteer’s chest during a 10-minute treadmill run wicked away sweat, MIT News says, while a silicone comparison became water-logged. In a second demonstration, a key-fob-sized patch on a volunteer’s neck during a 30-minute bike ride from MIT’s campus to Bunker Hill and back maintained “continuous and accurate” imaging of blood flow. Those are the demonstrations in the release. They are not a clinical trial, and they do not make the patch a cleared medical device.
The team says it is still working to streamline fabrication, and that it hopes later to use long-lasting wearable imagers to track athletes and to monitor patients outside clinic settings. That is an aim, not a product launch. Other ultrasound and wearable work already on TSN shows how wide the gap can be between a laboratory interface and a cleared device. A 3D-printed hologram method has been used to steer ultrasound toward stroke damage in mice, another research-stage ultrasound result, not a human treatment. By contrast, a Google smartwatch study in Nature flagged possible hypertension, and Empatica’s FDA-cleared WellPD system tracks Parkinson’s symptoms at home. Those last two are human studies or cleared monitoring tools. The MIT pad is not in that category yet.
A volunteer demonstration is not a clinical clearance
The facts that matter here are also the facts that bound the story. A dry bottlebrush elastomer transmitted ultrasound on a phantom for around nine days, wicked sweat in a 10-minute treadmill test, and, in MIT News’s wording, kept “continuous and accurate” blood-flow images on a volunteer’s neck during a 30-minute ride. The material is designed so that it does not dry out the way a hydrogel can within a day or two. Wang’s “like skin” description is about how the sample feels and holds together, not about clinical performance in a patient population.
None of that is a clinical validation, a named patient study of diagnostic accuracy, or a regulator’s clearance in the United States, the United Kingdom or elsewhere. Small volunteer demonstrations can be carefully done and still be only demonstrations. Until a larger clinical study or a regulatory filing is published, the accurate reading is the narrow one: a gel-free elastomer has been made and shown to carry ultrasound in a phantom and in short exercise tests on volunteers, and it has not been validated as a medical device. The next facts to watch are a streamlined fabrication method that others can repeat, a larger volunteer or patient study with named endpoints, or a regulator’s review. None of those is in the paper or the MIT News release.
How we sourced this
The quoted findings, the “around nine days” phantom result, and the 10-minute and 30-minute volunteer demonstrations are taken from MIT News and the Science paper, as set out in Research’s brief. No clinical or regulatory claim has been added.
Sources
- Shu Wang, Runze Li, Zihan Tang et al., “Interpenetrating bottlebrush elastomer for low-loss soft ultrasonic interfaces,” Science, 19 November 2026.
- Jennifer Chu, “Ultrasound imaging without the gel,” MIT News, 19 November 2026.
Get TSN’s biggest tech stories, explained.
News and insights across AI, tech, crypto and cybersecurity. Every source linked. Unsubscribe anytime.
Get the newsletterRelated stories
3D-Printed Holograms Steer Ultrasound to Stroke Damage in Mice is the closest recent TSN account of a research-stage ultrasound method that has not been shown as a human treatment, and is the next read.
- Google Smartwatch AI Flags Hypertension in Nature Study
- Empatica’s FDA-Cleared WellPD Tracks Parkinson’s Symptoms at Home
Follow @tsnmediahub on X for breaking AI news as it happens.
Follow on X


